Megan Garlapow, PhD

Most Recent Articles by Megan Garlapow, PhD

High Expression of DNA Repair Genes at Diagnosis Predictive of Early Relapse in Pediatric ALL

High Expression of DNA Repair Genes at Diagnosis Predictive of Early Relapse in Pediatric ALL

By

A data analysis revealed a genetic predictor of relapse for pediatric patients with ALL.

Adjuvant Radiation Therapy Improved Outcomes for Some With Advanced Head and Neck CSCC

Adjuvant Radiation Therapy Improved Outcomes for Some With Advanced Head and Neck CSCC

By

Researchers determined the 5-year overall and disease-free survival for patients with CSCC of the head and neck who received adjuvant radiation therapy.

Risk of Therapy-Related MDS, AML Increased by Use of Leukemogenic Chemotherapy Agents

Risk of Therapy-Related MDS, AML Increased by Use of Leukemogenic Chemotherapy Agents

By

Researchers sought to determine the association between chemotherapy, particularly platinum-based agents, and increased risk of tMDS/AML.

Neoadjuvant FOLFIRINOX a Better Option Than Surgery Plus Adjuvant Therapy in Pancreatic Cancer

Neoadjuvant FOLFIRINOX a Better Option Than Surgery Plus Adjuvant Therapy in Pancreatic Cancer

By

A decision-analysis was used to determine which treatment of BR/LA PDAC was more efficacious and more cost-effective: neoadjuvant FOLFIRINOX vs surgery with GEM/CAPE vs surgery with gemcitabine.

Radical Prostatectomy vs Active Surveillance: Results of Nearly 3 Decades of Follow-up

Radical Prostatectomy vs Active Surveillance: Results of Nearly 3 Decades of Follow-up

By

Researchers sought to determine the effect of radical prostatectomy vs watchful waiting on life expectancy in men with prostate cancer.

More Articles by Megan Garlapow, PhD

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs